What’s New in Breast Cancer? ESMO 2025 Updates
🎗 October was Breast Cancer Awareness Month and now it’s behind us. Now, I want to talk to you about what really matters: reality. My name is Nir Erez. I…
Meet Zongertinib (Hernexeos) – a breakthrough drug for patients with HER2‑mutant lung cancer
Meet Zongertinib (Hernexeos) – a breakthrough drug for patients with HER2‑mutant lung cancer Zongertinib (brand name: Hernexeos) is an innovative oral medication that acts as a selective HER2 receptor inhibitor…
Breakthrough Medical Vaccine for Glioblastoma (GBM): Personalized Life-Extending Immunotherapy
Breakthrough Medical Vaccine for Glioblastoma (GBM): Personalized Life-Extending Immunotherapy A new international study introduces an innovative therapeutic option for glioblastoma (GBM) patients: a personalized vaccine based on the genetic analysis…
🧠 New treatment for leptomeningeal metastases – hope for advanced-stage cancer patients
🧠 A new treatment for leptomeningeal metastases offers real hope for advanced-stage cancer patients. A groundbreaking study published in Nature Medicine and presented at ASCO 2025 shows promising clinical results…
New Treatment for Metastatic Triple Negative Breast Cancer – ASCO 2025
Metastatic Triple-Negative Breast Cancer: ASCO 2025 Highlights Breakthrough Therapy Metastatic triple-negative breast cancer (TNBC) is one of the most aggressive and difficult-to-treat forms of breast cancer, with limited standard treatment…
👨🍳 Tomasz Jakubiak Returns to Poland After Cancer Treatment in Israel
We’re happy to share some good news – the well-known and highly respected chef Tomasz Jakubiak has returned to Poland after an extended stay at an oncology hospital in…
Novel Drug Combination Shows Promising Results in HER2-Positive Metastatic Breast Cancer: Pyrotinib and Etoposide
*💡 What's This About?* A new study published in BMC Cancer examined an innovative combination of two drugs - Pyrotinib and *Etoposide* in metronomic dosing (low continuous dosing) in patients…
Encouraging News in Advanced Breast Cancer!
What's This About? A new study published in the prestigious The Lancet Oncology examined an innovative drug called Camizestrant in women with hormone-positive (ER+) and HER2-negative metastatic breast cancer, whose…
Success Story – Where There’s a Will, There’s a Way! 🌟
What happens when a patient with metastatic pancreatic cancer turns to us? Metastatic pancreatic cancer is a particularly challenging disease with a complex prognosis. Standard treatments are primarily based on…
Encouraging News in Metastatic Breast Cancer Treatment 🎯
📅 Posted on September 30, 2024 💡 What's This About? A new study examined the combination of two drugs – Eribulin and Carboplatin – in patients with "triple negative" metastatic…
- 1
- 2
- 3
- 4
- …
- 16
- Go to the next page